Video Experimental Relacionado
Updated: Aug 18, 2026
04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
La activación de las plaquetas humanas inducida por el éster de forbol está asociada con la fosforilación de la
Nature
|December 1, 1983
Resumen
El promotor tumoral 12-O-tetradecanoylphorbol-13-acetate (TPA) activa las plaquetas a través de la fosforilación de la cadena ligera de miosina, principalmente a través de la proteína quinasa C. Esta fosforilación inducida por TPA ocurre en un sitio distinto en comparación con la fosforilación inducida por trombina.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología celular Biología celular.
- Farmacología Farmacología.
Sus antecedentes:
- La activación de las plaquetas implica la fosforilación de la cadena ligera de miosina por la miosina.
- Los ésteres de forbol promotores de tumores, como el TPA, activan la proteína quinasa C y pueden inducir la agregación plaquetaria y la fosforilación de péptidos.
Objetivo del estudio:
- Para determinar si el péptido de 20.000 MW fosforilado por TPA es cadena ligera de miosina.
- Para diferenciar la fosforilación inducida por TPA de la fosforilación inducida por trombina del péptido de 20.000 MW.
Principales métodos:
- Pruebas de activación plaquetaria.
- Análisis de los patrones de fosforilación de las proteínas.
- Los ensayos de actividad enzimática para la proteína quinasa C y la miosina quinasa de cadena ligera.
Principales resultados:
- El TPA induce la fosforilación de la cadena ligera de 20.000 MW de la miosina plaquetaria.
- La fosforilación mediada por TPA es impulsada principalmente por la proteína kinasa C.
- El sitio de fosforilación al que apunta el TPA difiere del sitio fosforilado por la miosina en la cadena ligera kinasa.
Conclusiones:
- El TPA activa las plaquetas a través de una distinta vía de fosforilación de la cadena ligera de miosina que involucra a la proteína quinasa C.
- Este hallazgo diferencia el mecanismo del TPA de la activación plaquetaria inducida por la trombina, destacando eventos específicos de señalización.
Más Videos Relacionados
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Videos de Conceptos Relacionados
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...